ResearcherKanazawa UniversityActive in the last 2 years
Akihiro Seki
Matched on ORCID iD 0000-0002-0356-1810; OpenAlex author ID A5013160788. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 4 papers · 2026: 1 paper
Papers 7
- Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcinoma: a single-center case-control diagno… Co-author DOI 10.1038/s41598-026-58684-8↗
- Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer. Co-author DOI 10.1002/1878-0261.13796↗
- Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s44276-024-00116-z↗
- Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer. Last author DOI 10.21037/jgo-2025-601↗
- Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallbladder Cancer, in Which Follow-up Imagin… Co-author DOI 10.2169/internalmedicine.4581-24↗
- Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer … Co-author DOI 10.1136/jitc-2020-001367↗
- Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiation. Co-author DOI 10.1080/09553002.2019.1558297↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taro Yamashita · 5 shared papers, 2020–2026 · strength 1.04
- Paper Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcin… DOI 10.1038/s41598-026-58684-8↗
- Paper Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic … DOI 10.1002/1878-0261.13796↗
- Paper Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. DOI 10.1038/s44276-024-00116-z↗
- Alessandro Nasti · 4 shared papers, 2019–2025 · strength 0.85
- Paper Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer. DOI 10.21037/jgo-2025-601↗
- Paper Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic … DOI 10.1002/1878-0261.13796↗
- Paper Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response… DOI 10.1136/jitc-2020-001367↗
- Masaki Miyazawa · 3 shared papers, 2025–2026 · strength 0.69
- Paper Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcin… DOI 10.1038/s41598-026-58684-8↗
- Paper Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. DOI 10.1038/s44276-024-00116-z↗
- Paper Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallb… DOI 10.2169/internalmedicine.4581-24↗
- Takeshi Terashima · 3 shared papers, 2019–2025 · strength 0.47
- Paper Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. DOI 10.1038/s44276-024-00116-z↗
- Paper Metachronous Pancreatic Cancer with Pancreaticobiliary Maljunction Diagnosed Five Years after Cholecystectomy for Gallb… DOI 10.2169/internalmedicine.4581-24↗
- Paper Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiati… DOI 10.1080/09553002.2019.1558297↗
- Shuichi Kaneko · 3 shared papers, 2019–2025 · strength 0.42
- Paper Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic … DOI 10.1002/1878-0261.13796↗
- Paper Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response… DOI 10.1136/jitc-2020-001367↗
- Paper Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiati… DOI 10.1080/09553002.2019.1558297↗
- Yoshio Sakai · 3 shared papers, 2019–2025 · strength 0.42
- Paper Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic … DOI 10.1002/1878-0261.13796↗
- Paper Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response… DOI 10.1136/jitc-2020-001367↗
- Paper Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiati… DOI 10.1080/09553002.2019.1558297↗
- Tuyen Thuy Bich Ho · 2 shared papers, 2020–2025 · strength 0.35
- Paper Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic … DOI 10.1002/1878-0261.13796↗
- Paper Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response… DOI 10.1136/jitc-2020-001367↗
- Motoharu Seiki · 1 shared paper, 2025 · strength 0.20
- Naohiko Koshikawa · 1 shared paper, 2025 · strength 0.20
- Makoto Ueno · 1 shared paper, 2025 · strength 0.20
- Takuya Komura · 2 shared papers, 2019–2020 · strength 0.17
- Paper Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response… DOI 10.1136/jitc-2020-001367↗
- Paper Biological characteristics of gene expression features in pancreatic cancer cells induced by proton and X-ray irradiati… DOI 10.1080/09553002.2019.1558297↗
- Haruo Fujinaga · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.